版本:
中国

BRIEF-Acelrx Pharmaceuticals updates on notification from U.S. FDA

June 7 Acelrx Pharmaceuticals Inc:

* U.S. FDA notified co that it no longer plans to hold an advisory committee meeting in connection with its review of NDA for Dsuvia

* Decision does not alter PDUFA goal date for completion of review of NDA, which remains October 12, 2017 - SEC filing Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐